Labcorp to Announce Third Quarter Financial Results on October 24, 2024

9/24/24 4:16:00 PM ET

Medical Specialities

Health Care

Get the next $LH alert in real time by email

BURLINGTON, N.C., Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.

A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until September 10, 2025. To access the webcast recording, visit the Labcorp Investor Relations website.

About Labcorp

Labcorp (NYSE:LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-announce-third-quarter-financial-results-on-october-24-2024-302257649.html

SOURCE Labcorp Holdings Inc

Get the next $LH alert in real time by email

Recent Analyst Ratings for

$LH

Date	Price Target	Rating	Analyst
10/30/2024		Hold → Buy	HSBC Securities
10/1/2024	$235.00	Neutral	Piper Sandler
3/25/2024	$250.00	Hold → Buy	Argus
2/26/2024	$260.00	Outperform	Leerink Partners
2/9/2024	$240.00	In-line	Evercore ISI
1/3/2024	$222.00	Equal Weight	Barclays
9/6/2023	$210.00	Hold	HSBC Securities
12/12/2022	$275.00 → $250.00	Buy → Neutral	Citigroup

More analyst ratings

Labcorp to Announce Third Quarter Financial Results on October 24, 2024

Chat with this insight

Recent Analyst Ratings for $LH

$LH Leadership Updates

Live Leadership Updates

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors

Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

$LH SEC Filings

SEC Form 10-Q filed by Labcorp Holdings Inc.

Labcorp Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Labcorp Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

$LH Market Insights

Live Market Insights

Labcorp Says Systems Are Currently Impacted By The CrowdStrike Computer Outage Affecting Companies Globally

Labcorp Workers In Washington Ratify A New Contract; Three-year Contract Includes Higher Wages For Every Position, & Elimination Of Ghost Steps

Evercore ISI Group Maintains In-Line on Labcorp Holdings, Raises Price Target to $215

$LH Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

New insider Oyegunwa Akinbolade claimed ownership of 2,666 shares (SEC Form 3)

Director Anderson Kerrii B sold $230,000 worth of shares (1,000 units at $230.00), decreasing direct ownership by 7% to 13,722 units (SEC Form 4)

SEC Form 4 filed by Labcorp Holdings Inc.

$LH Press Releases

Fastest customizable press release news feed in the world

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

Labcorp Announces 2024 Third Quarter Results

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors

$LH Financials

Live finance-specific insights

$LH Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$LH Large Ownership Changes

This live feed shows all institutional transactions in real time.

Labcorp Announces 2024 Third Quarter Results

Labcorp Declares Quarterly Dividend

Labcorp to Announce Third Quarter Financial Results on October 24, 2024

Labcorp Holdings Inc. upgraded by HSBC Securities

Piper Sandler initiated coverage on Labcorp Holdings Inc. with a new price target

Laboratory Corp upgraded by Argus with a new price target

SEC Form SC 13G/A filed by Laboratory Corporation of America Holdings (Amendment)

SEC Form SC 13D/A filed by Laboratory Corporation of America Holdings (Amendment)

SEC Form SC 13G/A filed

Recent Analyst Ratings for
$LH

$LH
Leadership Updates

$LH
SEC Filings

$LH
Market Insights

$LH
Insider Trading

$LH
Press Releases

$LH
Financials

$LH
Analyst Ratings

$LH
Large Ownership Changes